Invention Grant
US08999940B2 Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal
有权
在N-末端修饰的葡萄糖依赖性促胰岛素多肽（GIP）的类似物
- Patent Title: Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal
- Patent Title (中): 在N-末端修饰的葡萄糖依赖性促胰岛素多肽（GIP）的类似物
-
Application No.: US13057966Application Date: 2009-08-07
-
Publication No.: US08999940B2Publication Date: 2015-04-07
- Inventor: Zheng Xin Dong
- Applicant: Zheng Xin Dong
- Applicant Address: FR Boulogne-Billancourt
- Assignee: Ipsen Pharma S.A.S.
- Current Assignee: Ipsen Pharma S.A.S.
- Current Assignee Address: FR Boulogne-Billancourt
- Agent Janice M. Klunder; Eileen J. Ennis
- International Application: PCT/US2009/004559 WO 20090807
- International Announcement: WO2010/016944 WO 20100211
- Main IPC: A61K38/16
- IPC: A61K38/16 ; C07K14/00 ; A61P3/10 ; A61P3/06 ; C07K14/605 ; A61K38/00
Abstract:
There is provided a novel series of analogues of glucose-dependent insulinotropic polypeptide compounds, pharmaceutical compositions containing said compounds, and the use of said compounds as GIP-receptor agonists or antagonists for treatment of GIP-receptor mediated conditions, such as non-insulin dependent diabetes mellitus and obesity.
Public/Granted literature
- US20110136725A1 ANALOGUES OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) MODIFIED AT N-TERMINAL Public/Granted day:2011-06-09
Information query
IPC分类:
